国药一致(000028) - 000028国药一致投资者关系管理信息20250903

Group 1: Financial Performance and Market Outlook - The company expects overall performance in the distribution sector to remain stable compared to last year, despite pressures from centralized procurement and payment reforms [2] - The net profit margin in the Guangdong market is significantly higher than competitors, with continued growth in public hospital market share [2] - The company has seen a substantial increase in credit impairment losses due to extended receivable collection periods and increased receivable scales [3] Group 2: Strategic Initiatives and Business Development - The company plans to enhance its capabilities in narcotic and psychotropic drug qualifications and improve internal collaboration for resource distribution [2] - There is a focus on accelerating the launch of new domestic and imported drugs to fill market gaps, alongside promoting hospital SPD projects [2] - The company is committed to digital transformation and smart logistics, which are expected to yield measurable cost savings and efficiency improvements [4] Group 3: Retail and Distribution Strategy - The company does not plan large-scale store closures in the near term, but is adapting to online sales pressures by enhancing product offerings and operational efficiency [3] - The retail sector's net profit margin is targeted to improve towards 3%, with strategies to optimize product categories and reduce costs [3] - The company emphasizes the importance of retail pharmacies in the pharmaceutical distribution chain, despite short-term pressures from regulatory changes [3] Group 4: Future Planning and Risk Management - The company is reviewing its "14th Five-Year Plan" and preparing for the "15th Five-Year Plan," focusing on market changes and organizational adjustments [4] - There is a commitment to maintaining a dividend policy of at least 20%, with current payouts exceeding 30% [4] - The company is enhancing its management of accounts receivable to ensure a reasonable return to levels, focusing on high-risk clients and overdue accounts [4]